Post-rituximab immunoglobulin M (IgM) hypogammaglobulinemia.
Sign Up to like & getrecommendations! Published in 2020 at "Autoimmunity reviews"
DOI: 10.1016/j.autrev.2020.102466
Abstract: Rituximab is a B cell depleting monoclonal antibody that targets the B cell-specific cell surface antigen CD20 and is currently used to treat several autoimmune diseases. The elimination of mature CD20-positive B lymphocytes committed to… read more here.
Keywords: rituximab; post rituximab; immunoglobulin; igm hypogammaglobulinemia ... See more keywords
Peripheral Ulcerative Keratitis in a Young Lady with Systemic Lupus Erythematosus Post Rituximab Infusion-A Case Report
Sign Up to like & getrecommendations! Published in 2022 at "Ocular Immunology and Inflammation"
DOI: 10.1080/09273948.2022.2037654
Abstract: ABSTRACT Aim We report a new ocular finding of episcleritis (OD) and peripheral ulcerative keratitis (OS) in a 40-year-old lady with a 13-year history of systemic lupus erythematosus (SLE), 3 weeks post-rituximab infusion. Materials &… read more here.
Keywords: peripheral ulcerative; rituximab infusion; post rituximab;
SAT0017 Investigating novel autoantibodies in patients with granulomatosis with polyangiitis
Sign Up to like & getrecommendations! Published in 2017 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2017-eular.3261
Abstract: Background Granulomatosis with polyangiitis (GPA) is a disease characterized by inflammation in small blood vessels, leading to significant organ damage and ultimately great morbidity and mortality. The presence of anti-neutrophil cytoplasmic antibodies (ANCAs) is a… read more here.
Keywords: post rituximab; novel autoantibodies; clonal families; remission ... See more keywords